APO Research
Talk to an analyst

APO RESEARCH · REPORT

Somatostatin Receptor Type 2

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Somatostatin Receptor Type 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025180 pages

Choose your research edition.

Industry ResearchSomatostatin Receptor Type 2 Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Somatostatin Receptor Type 2 Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Somatostatin Receptor Type 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Somatostatin Receptor Type 2 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Somatostatin Receptor Type 2 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Somatostatin Receptor Type 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Somatostatin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Somatostatin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Somatostatin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Somatostatin Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Somatostatin Receptor Type 2 include Amryt Pharma plc, Crinetics Pharmaceuticals Inc, Daewoong Pharmaceutical Co Ltd, Ipsen SA, Progenics Pharmaceuticals Inc, Strongbridge Biopharma plc and Zucara Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Somatostatin Receptor Type 2 market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Somatostatin Receptor Type 2 and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Somatostatin Receptor Type 2 revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Somatostatin Receptor Type 2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Somatostatin Receptor Type 2 Segment by Company

Amryt Pharma plc

Crinetics Pharmaceuticals Inc

Daewoong Pharmaceutical Co Ltd

Ipsen SA

Progenics Pharmaceuticals Inc

Strongbridge Biopharma plc

Zucara Therapeutics Inc

Somatostatin Receptor Type 2 Segment by Type

CRN-00808

PRL-2903

Lanreotide Acetate

Others

Somatostatin Receptor Type 2 Segment by Application

Oncology

Hormonal Disorder

Metabolic Disorder

Others

Somatostatin Receptor Type 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Somatostatin Receptor Type 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Somatostatin Receptor Type 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Somatostatin Receptor Type 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Somatostatin Receptor Type 2 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Somatostatin Receptor Type 2 industry.

Chapter 3: Detailed analysis of Somatostatin Receptor Type 2 companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Somatostatin Receptor Type 2revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of CRN-00808 Table 3. Key Players of PRL-2903 Table 4. Key Players of Lanreotide Acetate Table 3. Key Players of Others Table 4. Global Somatostatin Receptor Type 2 Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Oncology Table 6. Key Players of Hormonal Disorder Table 7. Key Players of Metabolic Disorder Table 8. Key Players of Others Table 9. Global Somatostatin Receptor Type 2 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Somatostatin Receptor Type 2 Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Somatostatin Receptor Type 2 Market Share by Region (2021-2026) Table 12. Global Somatostatin Receptor Type 2 Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Somatostatin Receptor Type 2 Market Share by Region (2027-2032) Table 14. Somatostatin Receptor Type 2 Industry Trends Table 15. Somatostatin Receptor Type 2 Industry Drivers Table 16. Somatostatin Receptor Type 2 Industry Opportunities and Challenges Table 17. Somatostatin Receptor Type 2 Industry Restraints Table 18. Global Somatostatin Receptor Type 2 Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Somatostatin Receptor Type 2 Revenue Market Share by Company (2021-2026) Table 20. Global Somatostatin Receptor Type 2 Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Somatostatin Receptor Type 2 Key Company Head Office and Area Served Table 22. Global Somatostatin Receptor Type 2 Company, Product Type & Application Table 23. Global Somatostatin Receptor Type 2 Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Somatostatin Receptor Type 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Somatostatin Receptor Type 2 Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Somatostatin Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Somatostatin Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2021-2026) Table 30. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2027-2032) Table 31. Global Somatostatin Receptor Type 2 Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Somatostatin Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Somatostatin Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2021-2026) Table 35. Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2027-2032) Table 36. Amryt Pharma plc Company Information Table 37. Amryt Pharma plc Business Overview Table 38. Amryt Pharma plc Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Amryt Pharma plc Somatostatin Receptor Type 2 Product Portfolio Table 40. Amryt Pharma plc Recent Development Table 41. Crinetics Pharmaceuticals Inc Company Information Table 42. Crinetics Pharmaceuticals Inc Business Overview Table 43. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product Portfolio Table 45. Crinetics Pharmaceuticals Inc Recent Development Table 46. Daewoong Pharmaceutical Co Ltd Company Information Table 47. Daewoong Pharmaceutical Co Ltd Business Overview Table 48. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product Portfolio Table 50. Daewoong Pharmaceutical Co Ltd Recent Development Table 51. Ipsen SA Company Information Table 52. Ipsen SA Business Overview Table 53. Ipsen SA Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Ipsen SA Somatostatin Receptor Type 2 Product Portfolio Table 55. Ipsen SA Recent Development Table 56. Progenics Pharmaceuticals Inc Company Information Table 57. Progenics Pharmaceuticals Inc Business Overview Table 58. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product Portfolio Table 60. Progenics Pharmaceuticals Inc Recent Development Table 61. Strongbridge Biopharma plc Company Information Table 62. Strongbridge Biopharma plc Business Overview Table 63. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product Portfolio Table 65. Strongbridge Biopharma plc Recent Development Table 66. Zucara Therapeutics Inc Company Information Table 67. Zucara Therapeutics Inc Business Overview Table 68. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product Portfolio Table 70. Zucara Therapeutics Inc Recent Development Table 71. North America Somatostatin Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 72. North America Somatostatin Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 73. North America Somatostatin Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 74. North America Somatostatin Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 75. North America Somatostatin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America Somatostatin Receptor Type 2 Market Size by Country (2021-2026) Table 77. North America Somatostatin Receptor Type 2 Market Size by Country (2027-2032) Table 78. Europe Somatostatin Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 79. Europe Somatostatin Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 80. Europe Somatostatin Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 81. Europe Somatostatin Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 82. Europe Somatostatin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. Europe Somatostatin Receptor Type 2 Market Size by Country (2021-2026) Table 84. Europe Somatostatin Receptor Type 2 Market Size by Country (2027-2032) Table 85. China Somatostatin Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 86. China Somatostatin Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 87. China Somatostatin Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 88. China Somatostatin Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 89. Asia Somatostatin Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 90. Asia Somatostatin Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 91. Asia Somatostatin Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 92. Asia Somatostatin Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia Somatostatin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Asia Somatostatin Receptor Type 2 Market Size by Country (2021-2026) Table 95. Asia Somatostatin Receptor Type 2 Market Size by Country (2027-2032) Table 96. South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Type (2021-2026) & (US$ Million) Table 97. South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Type (2027-2032) & (US$ Million) Table 98. South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Application (2021-2026) & (US$ Million) Table 99. South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Application (2027-2032) & (US$ Million) Table 100. South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2021-2026) Table 102. South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Somatostatin Receptor Type 2 Product Image Figure 2. Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Somatostatin Receptor Type 2 Market Share by Type: 2025 VS 2032 Figure 4. CRN-00808 Image Figure 5. PRL-2903 Image Figure 6. Lanreotide Acetate Image Figure 7. Others Image Figure 8. Global Somatostatin Receptor Type 2 Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Somatostatin Receptor Type 2 Market Share by Application: 2025 VS 2032 Figure 10. Oncology Image Figure 11. Hormonal Disorder Image Figure 12. Metabolic Disorder Image Figure 13. Others Image Figure 14. Global Somatostatin Receptor Type 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 16. Global Somatostatin Receptor Type 2 Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Somatostatin Receptor Type 2 Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Somatostatin Receptor Type 2 Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Somatostatin Receptor Type 2 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2021-2032) Figure 23. Global Somatostatin Receptor Type 2 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2021-2032) Figure 25. North America Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 26. North America Somatostatin Receptor Type 2 Market Share by Type (2021-2032) Figure 27. North America Somatostatin Receptor Type 2 Market Share by Application (2021-2032) Figure 28. North America Somatostatin Receptor Type 2 Market Share by Country (2021-2032) Figure 29. United States Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 30. Canada Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 32. Europe Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 33. Europe Somatostatin Receptor Type 2 Market Share by Type (2021-2032) Figure 34. Europe Somatostatin Receptor Type 2 Market Share by Application (2021-2032) Figure 35. Europe Somatostatin Receptor Type 2 Market Share by Country (2021-2032) Figure 36. Germany Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 37. France Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 39. Italy Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 40. Russia Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 42. China Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 43. China Somatostatin Receptor Type 2 Market Share by Type (2021-2032) Figure 44. China Somatostatin Receptor Type 2 Market Share by Application (2021-2032) Figure 45. Asia Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 46. Asia Somatostatin Receptor Type 2 Market Share by Type (2021-2032) Figure 47. Asia Somatostatin Receptor Type 2 Market Share by Application (2021-2032) Figure 48. Asia Somatostatin Receptor Type 2 Market Share by Country (2021-2032) Figure 49. Japan Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 53. India Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 54. Australia Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Somatostatin Receptor Type 2 Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Somatostatin Receptor Type 2 Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Somatostatin Receptor Type 2 Market Share by Country (2021-2032) Figure 59. Brazil Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 64. UAE Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 66. Chile Somatostatin Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • CRN-00808
  • PRL-2903
  • Lanreotide Acetate
  • Others
Applications
  • Oncology
  • Hormonal Disorder
  • Metabolic Disorder
  • Others
Companies covered
  • Amryt Pharma plc
  • Crinetics Pharmaceuticals Inc
  • Daewoong Pharmaceutical Co Ltd
  • Ipsen SA
  • Progenics Pharmaceuticals Inc
  • Strongbridge Biopharma plc
  • Zucara Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 CRN-00808
  5. 1.2.3 PRL-2903
  6. 1.2.4 Lanreotide Acetate
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Somatostatin Receptor Type 2 Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Oncology
  11. 1.3.3 Hormonal Disorder
  12. 1.3.4 Metabolic Disorder
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Somatostatin Receptor Type 2 Growth Trends by Region
  16. 1.5.1 Global Somatostatin Receptor Type 2 Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Somatostatin Receptor Type 2 Market Size by Region (2021-2026)
  18. 1.5.3 Somatostatin Receptor Type 2 Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Somatostatin Receptor Type 2 Market Dynamics
  1. 2.1 Somatostatin Receptor Type 2 Industry Trends
  2. 2.2 Somatostatin Receptor Type 2 Industry Drivers
  3. 2.3 Somatostatin Receptor Type 2 Industry Opportunities and Challenges
  4. 2.4 Somatostatin Receptor Type 2 Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Somatostatin Receptor Type 2 Revenue by Company (2021-2026)
  2. 3.2 Global Somatostatin Receptor Type 2 Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Somatostatin Receptor Type 2 Key Company Head office and Area Served
  4. 3.4 Global Somatostatin Receptor Type 2 Company, Product Type & Application
  5. 3.5 Global Somatostatin Receptor Type 2 Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Somatostatin Receptor Type 2 Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Somatostatin Receptor Type 2 Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Somatostatin Receptor Type 2 Tier 1, Tier 2, and Tier 3
4 Somatostatin Receptor Type 2 Market by Type
  1. 4.1 Global Somatostatin Receptor Type 2 Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Somatostatin Receptor Type 2 Market Size by Type (2021-2032)
  3. 4.3 Global Somatostatin Receptor Type 2 Market Size Share by Type (2021-2032)
5 Somatostatin Receptor Type 2 Market by Application
  1. 5.1 Global Somatostatin Receptor Type 2 Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Somatostatin Receptor Type 2 Market Size by Application (2021-2032)
  3. 5.3 Global Somatostatin Receptor Type 2 Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Amryt Pharma plc
  2. 6.1.1 Amryt Pharma plc Company Information
  3. 6.1.2 Amryt Pharma plc Business Overview
  4. 6.1.3 Amryt Pharma plc Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Amryt Pharma plc Somatostatin Receptor Type 2 Product Portfolio
  6. 6.1.5 Amryt Pharma plc Recent Developments
  7. 6.2 Crinetics Pharmaceuticals Inc
  8. 6.2.1 Crinetics Pharmaceuticals Inc Company Information
  9. 6.2.2 Crinetics Pharmaceuticals Inc Business Overview
  10. 6.2.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product Portfolio
  12. 6.2.5 Crinetics Pharmaceuticals Inc Recent Developments
  13. 6.3 Daewoong Pharmaceutical Co Ltd
  14. 6.3.1 Daewoong Pharmaceutical Co Ltd Company Information
  15. 6.3.2 Daewoong Pharmaceutical Co Ltd Business Overview
  16. 6.3.3 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product Portfolio
  18. 6.3.5 Daewoong Pharmaceutical Co Ltd Recent Developments
  19. 6.4 Ipsen SA
  20. 6.4.1 Ipsen SA Company Information
  21. 6.4.2 Ipsen SA Business Overview
  22. 6.4.3 Ipsen SA Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Ipsen SA Somatostatin Receptor Type 2 Product Portfolio
  24. 6.4.5 Ipsen SA Recent Developments
  25. 6.5 Progenics Pharmaceuticals Inc
  26. 6.5.1 Progenics Pharmaceuticals Inc Company Information
  27. 6.5.2 Progenics Pharmaceuticals Inc Business Overview
  28. 6.5.3 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product Portfolio
  30. 6.5.5 Progenics Pharmaceuticals Inc Recent Developments
  31. 6.6 Strongbridge Biopharma plc
  32. 6.6.1 Strongbridge Biopharma plc Company Information
  33. 6.6.2 Strongbridge Biopharma plc Business Overview
  34. 6.6.3 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product Portfolio
  36. 6.6.5 Strongbridge Biopharma plc Recent Developments
  37. 6.7 Zucara Therapeutics Inc
  38. 6.7.1 Zucara Therapeutics Inc Company Information
  39. 6.7.2 Zucara Therapeutics Inc Business Overview
  40. 6.7.3 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product Portfolio
  42. 6.7.5 Zucara Therapeutics Inc Recent Developments
7 North America
  1. 7.1 North America Somatostatin Receptor Type 2 Market Size (2021-2032)
  2. 7.2 North America Somatostatin Receptor Type 2 Market Size by Type
  3. 7.2.1 North America Somatostatin Receptor Type 2 Market Size by Type (2021-2026)
  4. 7.2.2 North America Somatostatin Receptor Type 2 Market Size by Type (2027-2032)
  5. 7.2.3 North America Somatostatin Receptor Type 2 Market Share by Type (2021-2032)
  6. 7.3 North America Somatostatin Receptor Type 2 Market Size by Application
  7. 7.3.1 North America Somatostatin Receptor Type 2 Market Size by Application (2021-2026)
  8. 7.3.2 North America Somatostatin Receptor Type 2 Market Size by Application (2027-2032)
  9. 7.3.3 North America Somatostatin Receptor Type 2 Market Share by Application (2021-2032)
  10. 7.4 North America Somatostatin Receptor Type 2 Market Size by Country
  11. 7.4.1 North America Somatostatin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Somatostatin Receptor Type 2 Market Size by Country (2021-2026)
  13. 7.4.3 North America Somatostatin Receptor Type 2 Market Size by Country (2027-2032)
  14. 7.4.4 North America Somatostatin Receptor Type 2 Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Somatostatin Receptor Type 2 Market Size (2021-2032)
  2. 8.2 Europe Somatostatin Receptor Type 2 Market Size by Type
  3. 8.2.1 Europe Somatostatin Receptor Type 2 Market Size by Type (2021-2026)
  4. 8.2.2 Europe Somatostatin Receptor Type 2 Market Size by Type (2027-2032)
  5. 8.2.3 Europe Somatostatin Receptor Type 2 Market Share by Type (2021-2032)
  6. 8.3 Europe Somatostatin Receptor Type 2 Market Size by Application
  7. 8.3.1 Europe Somatostatin Receptor Type 2 Market Size by Application (2021-2026)
  8. 8.3.2 Europe Somatostatin Receptor Type 2 Market Size by Application (2027-2032)
  9. 8.3.3 Europe Somatostatin Receptor Type 2 Market Share by Application (2021-2032)
  10. 8.4 Europe Somatostatin Receptor Type 2 Market Size by Country
  11. 8.4.1 Europe Somatostatin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Somatostatin Receptor Type 2 Market Size by Country (2021-2026)
  13. 8.4.3 Europe Somatostatin Receptor Type 2 Market Size by Country (2027-2032)
  14. 8.4.4 Europe Somatostatin Receptor Type 2 Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Somatostatin Receptor Type 2 Market Size (2021-2032)
  2. 9.2 China Somatostatin Receptor Type 2 Market Size by Type
  3. 9.2.1 China Somatostatin Receptor Type 2 Market Size by Type (2021-2026)
  4. 9.2.2 China Somatostatin Receptor Type 2 Market Size by Type (2027-2032)
  5. 9.2.3 China Somatostatin Receptor Type 2 Market Share by Type (2021-2032)
  6. 9.3 China Somatostatin Receptor Type 2 Market Size by Application
  7. 9.3.1 China Somatostatin Receptor Type 2 Market Size by Application (2021-2026)
  8. 9.3.2 China Somatostatin Receptor Type 2 Market Size by Application (2027-2032)
  9. 9.3.3 China Somatostatin Receptor Type 2 Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Somatostatin Receptor Type 2 Market Size (2021-2032)
  2. 10.2 Asia Somatostatin Receptor Type 2 Market Size by Type
  3. 10.2.1 Asia Somatostatin Receptor Type 2 Market Size by Type (2021-2026)
  4. 10.2.2 Asia Somatostatin Receptor Type 2 Market Size by Type (2027-2032)
  5. 10.2.3 Asia Somatostatin Receptor Type 2 Market Share by Type (2021-2032)
  6. 10.3 Asia Somatostatin Receptor Type 2 Market Size by Application
  7. 10.3.1 Asia Somatostatin Receptor Type 2 Market Size by Application (2021-2026)
  8. 10.3.2 Asia Somatostatin Receptor Type 2 Market Size by Application (2027-2032)
  9. 10.3.3 Asia Somatostatin Receptor Type 2 Market Share by Application (2021-2032)
  10. 10.4 Asia Somatostatin Receptor Type 2 Market Size by Country
  11. 10.4.1 Asia Somatostatin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Somatostatin Receptor Type 2 Market Size by Country (2021-2026)
  13. 10.4.3 Asia Somatostatin Receptor Type 2 Market Size by Country (2027-2032)
  14. 10.4.4 Asia Somatostatin Receptor Type 2 Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Somatostatin Receptor Type 2 Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst